Yang et al. [43] also found that Cinobufacin can inhibit the growth of human bladder cancer cells in vivo and in vitro through Fas/Fasl and TNF-α/TNFR1 pathways. The gene discussed is FAS; the disease is urinary bladder carcinoma.